메뉴 건너뛰기




Volumn 17, Issue 8, 2008, Pages 1113-1115

Conducting a European multi-center trial: First experiences with the new EU Clinical Trials Directive from an academic perspective

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CONCEPTUAL FRAMEWORK; DRUG RESEARCH; GOOD CLINICAL PRACTICE; HEALTH CARE POLICY; MONITORING; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH ETHICS; SHORT SURVEY; UNIVERSITY HOSPITAL;

EID: 49249094300     PISSN: 09406719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00586-008-0699-5     Document Type: Short Survey
Times cited : (8)

References (14)
  • 1
    • 0035843129 scopus 로고    scopus 로고
    • Is the university-industrial complex out of control?
    • Anonymous
    • Anonymous (2001) Is the university-industrial complex out of control? Nature 409(6817):119
    • (2001) Nature , vol.409 , Issue.6817 , pp. 119
  • 2
    • 0038167780 scopus 로고    scopus 로고
    • Who's afraid of the European clinical trials Directive?
    • Anonymous
    • Anonymous (2003) Who's afraid of the European clinical trials Directive? Lancet 361(9376):2167
    • (2003) Lancet , vol.361 , Issue.9376 , pp. 2167
  • 3
    • 0034682156 scopus 로고    scopus 로고
    • Uneasy alliance-clinical investigators and the pharmaceutical industry
    • 20
    • T Bodenheimer 2000 Uneasy alliance-clinical investigators and the pharmaceutical industry N Engl J Med 342 20 1539 1544
    • (2000) N Engl J Med , vol.342 , pp. 1539-1544
    • Bodenheimer, T.1
  • 4
    • 0003177157 scopus 로고    scopus 로고
    • Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
    • Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official J Eur Communities 2001, L121:34-44
    • (2001) Official J Eur Communities , vol.L121 , pp. 34-44
  • 5
    • 0032724035 scopus 로고    scopus 로고
    • Evaluation of conflict of interest in economic analyses of new drugs used in oncology
    • 15
    • M Friedberg B Saffran TJ Stinson W Nelson CL Bennett 1999 Evaluation of conflict of interest in economic analyses of new drugs used in oncology JAMA 282 15 1453 1457
    • (1999) JAMA , vol.282 , pp. 1453-1457
    • Friedberg, M.1    Saffran, B.2    Stinson, T.J.3    Nelson, W.4    Bennett, C.L.5
  • 6
    • 0038777090 scopus 로고    scopus 로고
    • Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications
    • 7400
    • H Melander J Hlqvist-Rastad G Meijer B Beermann 2003 Evidence b(i)ased medicine-selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications BMJ 326 7400 1171 1173
    • (2003) BMJ , vol.326 , pp. 1171-1173
    • Melander, H.1    Hlqvist-Rastad, J.2    Meijer, G.3    Beermann, B.4
  • 7
    • 0038637754 scopus 로고    scopus 로고
    • The death of academic clinical trials
    • 9368
    • AH Morice 2003 The death of academic clinical trials Lancet 361 9368 1568
    • (2003) Lancet , vol.361 , pp. 1568
    • Morice, A.H.1
  • 8
    • 0842330269 scopus 로고    scopus 로고
    • Save European research campaign
    • 7434
    • B Moulton 2004 Save European research campaign BMJ 328 7434 286
    • (2004) BMJ , vol.328 , pp. 286
    • Moulton, B.1
  • 10
    • 0035841614 scopus 로고    scopus 로고
    • Modulating the profit motive to meet needs of the less-developed world
    • 9293
    • A Schieppati G Remuzzi S Garattini 2001 Modulating the profit motive to meet needs of the less-developed world Lancet 358 9293 1638 1641
    • (2001) Lancet , vol.358 , pp. 1638-1641
    • Schieppati, A.1    Remuzzi, G.2    Garattini, S.3
  • 11
    • 0032495544 scopus 로고    scopus 로고
    • Conflict of interest in the debate over calcium-channel antagonists
    • 2
    • HT Stelfox G Chua K O'Rourke AS Detsky 1998 Conflict of interest in the debate over calcium-channel antagonists N Engl J Med 338 2 101 106
    • (1998) N Engl J Med , vol.338 , pp. 101-106
    • Stelfox, H.T.1    Chua, G.2    O'Rourke, K.3    Detsky, A.S.4
  • 12
    • 0037157590 scopus 로고    scopus 로고
    • Drug development for neglected diseases: A deficient market and a public-health policy failure
    • 9324
    • P Trouiller P Olliaro E Torreele J Orbinski R Laing N Ford 2002 Drug development for neglected diseases: a deficient market and a public-health policy failure Lancet 359 9324 2188 2194
    • (2002) Lancet , vol.359 , pp. 2188-2194
    • Trouiller, P.1    Olliaro, P.2    Torreele, E.3    Orbinski, J.4    Laing, R.5    Ford, N.6
  • 13
    • 49249094878 scopus 로고    scopus 로고
    • Challenges of the Clinical Trial Directive for non-commercial cinical trials
    • 27-2-2004. Ref Type: Internet Communication
    • Vandendael K (2004) Challenges of The Clinical Trial Directive for non-commercial cinical trials. Newsletter of Federation of European Cancer Societies. 27-2-2004. Ref Type: Internet Communication
    • (2004) Newsletter of Federation of European Cancer Societies
    • Vandendael, K.1
  • 14
    • 0842308693 scopus 로고    scopus 로고
    • Implementing the European clinical trials directive
    • 7434
    • K Woods 2004 Implementing the European clinical trials directive BMJ 328 7434 240 241
    • (2004) BMJ , vol.328 , pp. 240-241
    • Woods, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.